WAT

Rating buyAI Memo

Waters

As of 2026-02-10/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-02-10 • Model: RankAlpha Sentiment AI

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

buy

Confidence

medium

Horizon

—

Key catalyst

Next quarterly earnings (estimated) • 2026-05-11

Expected move: +6%

Biggest risk

Bear case: softer end‑market demand, weaker guidance, or further analyst downgrades compress multiples and leave the stock near the low end of consensus; downside is concentrated around guidance-driven re-rating [#SERP-8].

Invalidation

Break below $328 or thesis failure.

What would change my mind?

Bull case: continued strength in biopharma R&D spending, recurring consumables growth, and successful new-product ramps push revenue and margins above consensus, validating analyst highs and supporting a move toward $480.0 [#SERP-4].

Research note

Recommendation

buy

Confidence

medium

As of

2026-02-10

Base target

$389

p=60%

Bull target

$480

p=25%

Bear target

$328

p=15%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Next quarterly earnings (estimated)
Analyst target revisions / downgrades
Commercial rollouts and consumables growth

BearKey bullets

Analyst downgrades causing multiple compression
Guidance or earnings misses from weak instrument orders
Supply-chain or FX-driven margin pressure

WatchKey bullets

ANCHOR: {"price": 327.81, "timestamp_utc": "2026-02-10T14:19:12+00:00", "source": "broker_last"} ANALYST_TARGETS_REVIEWED: true Targets are set relative to the authoritative anchor above and calibrated to the analyst consensus range.

Summary

High-level snapshot

Recommendation

buy

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $389 (p=60%)

Bull/Bear spread: +31% / -11%

Vs latest close: Bull +31% · Base +6% · Bear -11%

Scenario probabilities

Bull Target: $480 (p=25%)Base Target: $389 (p=60%)Bear Target: $328 (p=15%)

Commentary

Sentiment is cautiously constructive: the analyst median sits above the current anchor, implying base‑case upside, but wide target dispersion and recent downgrades introduce near‑term risk ahead of earnings [#SERP-1][#SERP-8]. Investors are focused on instrument orders, margin trends, and recurring‑revenue momentum as the primary catalysts that will validate or erode the current consensus.

As of 2026-02-10 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Next quarterly earnings (estimated)
Analyst target revisions / downgrades
Commercial rollouts and consumables growth

Human Analyst Targets

External snippets for comparison only; verify at source.

Unverified externalLast fetched 2026-02-10Source quality: external scrape

External snippets are unverified; treat as directional signals only. Always confirm with the original provider.

Inline RA est

Provider

serper

Median (USD)

$389.00

Range (USD)

$328.14 - $480.00

Count

Query: Waters Corp Common (WAT) analyst consensus price target high low average

Waters (WAT) Stock Forecast & Price Target - Investing.com
Search result #1
According to projections from 19 analysts, the average 12-month price target for Waters is 412.63, with a high estimate of 480 and a low estimate of 330. What ...
Open source
Waters Corporation (WAT) Analyst Ratings, Estimates & Forecasts
Search result #2
See Waters Corporation (WAT) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Open source
WAT Analyst Ratings for Waters Corp Stock - Barchart.com
Search result #3
Above the chart, you will find the 12-Month High, Mean, and Low Target Prices from analysts who provided ratings. ... The table shows the mean historical analyst ...
Open source
Waters Corporation: Target Price Consensus and Analysts ...
Search result #4
Last Close Price. 381.29USD. Average target price. 416.94USD. Spread / Average Target. +9.35%. High Price Target. 480.00USD. Spread / Highest target. +25.89%.
Extracted: $381.29, $416.94, $480.00Open source
WAT | Waters Corp. Analyst Estimates - MarketWatch
Search result #5
Stock Price Targets. High, $480.00. Median, $423.00. Low, $360.00. Average, $421.82. Current Price, $376.89. Yearly Numbers. Estimates. WAT will report 2025 ...
Extracted: $480.00, $423.00, $360.00, $421.82, $376.89Open source
What is the current Price Target and Forecast for Waters (WAT)
Search result #6
The forecasts range from a low of $360.00 to a high of $480.00. The average price target represents an increase of 11.92% from the last closing price of $376. ...
Extracted: $360.00, $480.00, $376.00Open source

Scenarios

Bull Target (Scenario probability)

$480 / p=25% prob

Base Target (Scenario probability)

$389 / p=60% prob

Bear Target (Scenario probability)

$328 / p=15% prob

Price $367 as of 2026-05-28

Nearest Scenario: Base (∆ 6%)

Targets vs latest close: Bull +31% · Base +6% · Bear -11%

Sentiment & Exposure

Sentiment unavailable: insufficient coverage

Short-term Catalysts

Next few weeks

Next quarterly earnings (estimated)
2026-05-11
Quarterly results and guidance versus consensus; an EPS/revenue beat could re-rate the stock toward analyst median/targets, while a miss could validate recent lower targets [#SERP-1][#SERP-5].
Prob 65% • Move 12% • Priced-in 40%
Analyst target revisions / downgrades
2026-05-11
Recent downward target moves (e.g., TD Cowen coverage note) show sensitivity to guidance; additional cuts or upgrades over the next quarter could cap or unlock upside [#SERP-8].
Prob 50% • Move 7% • Priced-in 60%

Long-term Catalysts

Months to a year

Commercial rollouts and consumables growth
2027-02-10
Sustained adoption of high-margin separations products and recurring consumables could materially expand margins and justify valuation above consensus within a year [#SERP-4].
Prob 40% • Move 30% • Priced-in 15%

Risks

Analyst downgrades causing multiple compression
Guidance or earnings misses from weak instrument orders
Supply-chain or FX-driven margin pressure

Peers

Symbol	Summary
TMO	Large life‑sciences tools company with broad consumables and services exposure; serves similar end markets.
A	Analytical instruments and services provider focused on chromatography and mass spectrometry; comparable product cycles.
DHR	Diversified medical and lab technologies platform with strong recurring revenue and acquisition-driven growth.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment AI
Human targets: serper
Targets query: Waters Corp Common (WAT) analyst consensus price target high low average
Analysis date: 2026-02-10

Loading AI feed…

Symbol

Summary

TMO

Large life‑sciences tools company with broad consumables and services exposure; serves similar end markets.

Analytical instruments and services provider focused on chromatography and mass spectrometry; comparable product cycles.

DHR

Diversified medical and lab technologies platform with strong recurring revenue and acquisition-driven growth.